NRSN•benzinga•
NeuroSense Therapeutics To Present Data From PrimeC's Phase 2b Trial In ALS At Annual American Academy of Neurology Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 4, 2025 by benzinga